TITLE

Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models

AUTHOR(S)
Lee, O H; Bae, S K; Bae, M H; Lee, Y M; Moon, E J; Cha, H J; Kwon, Y G; Kim, K W
PUB. DATE
January 2000
SOURCE
British Journal of Cancer;1/15/2000, Vol. 82 Issue 2, p385
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Insulin-like growth factor II (IGF-II), highly expressed in a number of human tumours, has been recently known to promote neovascularization in vivo. Yet, the detailed mechanism by which IGF-II induces angiogenesis has not been well defined. In the present study, we explored an angiogenic activity of IGF-II in in vitro angiogenesis model. Human umbilical vein endothelial cells (HUVECs) treated with IGF-II rapidly aligned and formed a capillary-like network on Matrigel. In chemotaxis assay, IGF-II remarkably increased migration of HUVECs. A rapid and transient activation of p38 mitogen-activated protein kinase (p38 MAPK) and p125 focal adhesion kinase (p125[SUPFAK]) phosphorylation was detected in HUVECs exposed to IGF-II. IGF-II also stimulated invasion of HUVECs through a polycarbonate filter coated with Matrigel. Quantitative gelatin-based zymography identified that matrix metalloproteinase-2 (MMP-2) activity generated from HUVECs was increased by IGF-II. This induction of MMP-2 activity was correlated with Northern blot analysis, showing in HUVECs that IGF-II increased the expression of MMP-2 mRNA, while it did not affect that of TIMP-2, a tissue inhibitor of MMP-2. These results provide the evidence that IGF-II directly induces angiogenesis by stimulating migration and morphological differentiation of endothelial cells, and suggest that IGF-II may play a crucial role in the progression of tumorigenesis by promoting the deleterious neovascularization.
ACCESSION #
8877170

 

Related Articles

  • IGFBP-4 Anti-Angiogenic and Anti-Tumorigenic Effects Are Associated with Anti-Cathepsin B Activity. Moreno, María J.; Ball, Marguerite; Rukhlova, Marina; Slinn, Jacqueline; L'Abbe, Denis; Iqbal, Umar; Monette, Robert; Hagedorn, Martin; O'Connor-McCourt, Maureen D.; Durocher, Yves; Stanimirovic, Danica B. // Neoplasia;May2013, Vol. 15 Issue 5, p554 

    Insulin-like growth factor--binding protein 4 (IGFBP-4/IBP-4) has potent IGF-independent anti-angiogenic and anti-tumorigenic effects. In this study, we demonstrated that these activities are located in the IGFBP-4 C-terminal protein fragment (CIBP-4), a region containing a thyroglobulin type 1...

  • Insulin-like growth factor-binding protein-6 and cancer. BACH, Leon A.; FU, Ping; YANG, Zhiyong // Clinical Science;2013, Vol. 124 Issue 4, p215 

    The IGF (insulin-like growth factor) system is essential for physiological growth and it is also implicated in a number of diseases including cancer. IGF activity is modulated by a family of high-affinity IGF-binding proteins, and IGFBP-6 is distinctive because of its marked binding preference...

  • IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells. Azar, W J; Zivkovic, S; Werther, G A; Russo, V C // Oncogene;1/30/2014, Vol. 33 Issue 5, p578 

    IGFBP-2 is highly expressed in both the serum and tumor tissues of most cancers, and is considered one of the most significant genes in the signature of major cancers. IGFBP-2 mainly modulates IGF actions in the pericellular space; however, there is considerable evidence to suggest that IGFBP-2...

  • Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Iwatsuki, Ken; Tanaka, Kiyoko; Kaneko, Tsuyoshi; Kazama, Ritsuko; Okamoto, Shiki; Nakayama, Yuki; Ito, Yoshiaki; Satake, Masanobu; Takahashi, Shin-Ichiro; Miyajima, Atsushi; Watanabe, Toshio; Hara, Takahiko // Oncogene;2/10/2005, Vol. 24 Issue 7, p1129 

    Mouse embryos lacking the Runx1 transcription factor exhibit an angiogenic defect accompanied by the absence of hematopoietic stem cells (HSCs). To ask whether Runx1 plays a direct role in angiogenesis, we established a novel endothelial progenitor cell line, designated AEL-?R1, from the...

  • Blood-borne angiogenic factors and sustained multiple implantation: a comparison of singleton and twin pregnancies. Groeneveld, Els; Lambers, Marieke J.; Hoozemans, Diederik A.; Schats, Roel; Hompes, Peter G. A.; Lambalk, Cornelis B. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2010, Vol. 20 Issue 6, p822 

    This study aimed to compare longitudinal serum concentrations of angiogenic implantation factors between ongoing singleton and twin pregnancies after double-embryo transfer and to investigate whether these are involved in sustained double implantation. Sixteen patients with an ongoing singleton...

  • Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis. Seung Bae Rho; Seung Myung Dong; Sokbom Kang; Sang-Soo Seo; Chong Woo Yoo; Dong Ock Lee; Jong Soo Woo; Sang-Yoon Park // Carcinogenesis;Nov2008, Vol. 29 Issue 11, p2106 

    Insulin-like growth factor-binding protein-5 (IGFBP-5) is one of the six members of IGFBP family, important for cell growth control, induction of apoptosis and other IGF-stimulated signaling pathways. In this study, we focused on characterizing the specific function of IGFBP-5 as novel...

  • Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis. Kai-Da Wu; Li Zhou; Burtrum, Douglas; Ludwig, Dale; Moore, Malcolm // Cancer Immunology, Immunotherapy;Mar2007, Vol. 56 Issue 3, p343 

    Although many multiple myeloma (MM) patients initially respond to cytotoxic therapy, most eventually relapse. Novel therapeutic strategies employing a combination of chemotherapy with targeted biologics may significantly enhance the response of tumor cells to treatment. We tested a fully human...

  • Insulin-Like Growth Factor 1 and Physical Activity.  // Journal of Aging & Physical Activity;Jul1994, Vol. 2 Issue 3, p280 

    An abstract of the article "Serum insulin-like growth factor 1 in healthy older men in relation to physical activity," by D. Rudman and D.E. Mattson, in "Journal of the American Geriatrics Society," issue 42, is presented.

  • Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Moorehead, R A; Fata, J E; Johnson, M B; Khokha, R // Cell Death & Differentiation;Jan2001, Vol. 8 Issue 1, p16 

    IGF-II is a growth factor implicated in human cancers and animal tumor models. While the mitogenic properties of IGF-II are well documented, its ability to suppress apoptosis in vivo has never been proven. We generated independent MMTVIGF-II transgenic mice to examine the control of epithelial...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics